The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Open accessAbstract
Neuraminidase is one of the two surface glycoproteins of influenza A and B viruses. It has enzymatic activity that cleaves terminal sialic acid from glycans, and that activity is essential at several points in the virus life cycle. While neuraminidase is a major target for influenza antivirals, it is largely ignored in vaccine development. Current inactivated influenza virus vaccines might contain neuraminidase, but the antigen quantity and quality are varied and not standardized. While there are data that show a protective role of anti-neuraminidase immunity, many questions remain unanswered. These questions, among others, concern the targeted epitopes or antigenic sites, the potential for antigenic drift, and, connected to that, the breadth of protection, differences in induction of immune responses by vaccination versus infection, mechanisms of protection, the role of mucosal antineuraminidase antibodies, stability, and the immunogenicity of neuraminidase in vaccine formulations. Reagents for analysis of neuraminidase-based immunity are scarce, and assays are not widely used for clinical studies evaluating vaccines. However, efforts to better understand neuraminidase-based immunity have been made recently. A neuraminidase focus group, NAction!, was formed at a Centers of Excellence for Influenza Research and Surveillance meeting at the National Institutes of Health in Bethesda, MD, to promote research that helps to understand neuraminidase-based immunity and how it can contribute to the design of better and broadly protective influenza virus vaccines. Here, we review open questions and knowledge gaps that have been identified by this group and discuss how the gaps can be addressed, with the ultimate goal of designing better influenza virus vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human and avian influenza viruses target different cell types in cultures of human airway epithelium
Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A., & Klenk, H.-D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308001101 · Cited by 781
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A., & Klenk, H.-D. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12665-12667.2004 · Cited by 606
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Self-citationRole of receptor binding specificity in influenza A virus transmission and pathogenesis
de Graaf, M., & Fouchier, R. A. M. (2014) · The EMBO Journal · doi:10.1002/embj.201387442 · Cited by 435
Self-citationMucins, Mucus, and Goblet Cells
Ma, J., Rubin, B. K., & Voynow, J. A. (2018) · Chest · doi:10.1016/j.chest.2017.11.008 · Cited by 413
Memoli, M. J., Shaw, P. A., Han, A., Czajkowski, L., Reed, S., Athota, R., Bristol, T., Fargis, S., Risos, K., Powers, J. H., et al. (2016) · mBio · doi:10.1128/mbio.00417-16 · Cited by 374
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
Monto, A. S., Petrie, J. G., Cross, R. T., Johnson, E., Liu, M., Zhong, W., Levine, M., Katz, J. M., & Ohmit, S. E. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv195 · Cited by 369
Self-citationInfluenza A penetrates host mucus by cleaving sialic acids with neuraminidase
Cohen, M., Zhang, X.-Q., Senaati, H. P., Chen, H.-W., Varki, N. M., Schooley, R. T., & Gagneux, P. (2013) · Virology Journal · doi:10.1186/1743-422x-10-321 · Cited by 288
Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase
Kilbourne, E. D., Laver, W. G., Schulman, J. L., & Webster, R. G. (1968) · Journal of Virology · doi:10.1128/jvi.2.4.281-288.1968 · Cited by 287
Couch, R. B., Atmar, R. L., Franco, L. M., Quarles, J. M., Wells, J., Arden, N., Niño, D., & Belmont, J. W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis935 · Cited by 280
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
Sandbulte, M. R., Westgeest, K. B., Gao, J., Xu, X., Klimov, A. I., Russell, C. A., Burke, D. F., Smith, D. J., Fouchier, R. A. M., & Eichelberger, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113801108 · Cited by 261
Self-citationStructural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
Xu, X., Zhu, X., Dwek, R. A., Stevens, J., & Wilson, I. A. (2008) · Journal of Virology · doi:10.1128/jvi.00959-08 · Cited by 260
Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L., & Kilbourne, E. D. (1974) · Journal of Infectious Diseases · doi:10.1093/infdis/129.4.411 · Cited by 257
Influenza virus neuraminidase activates latent transforming growth factor beta
Schultz-Cherry, S., & Hinshaw, V. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8624-8629.1996 · Cited by 244
Wohlbold, T. J., Nachbagauer, R., Xu, H., Tan, G. S., Hirsh, A., Brokstad, K. A., Cox, R. J., Palese, P., & Krammer, F. (2015) · mBio · doi:10.1128/mbio.02556-14 · Cited by 233
Self-citationCouzens, L., Gao, J., Westgeest, K., Sandbulte, M., Lugovtsev, V., Fouchier, R., & Eichelberger, M. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.09.003 · Cited by 187
Self-citationHe, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 182
Self-citationInfluenza A virus hemagglutinin and neuraminidase act as novel motile machinery
Sakai, T., Nishimura, S. I., Naito, T., & Saito, M. (2017) · Scientific Reports · doi:10.1038/srep45043 · Cited by 180
The Pathway to a Universal Influenza Vaccine
Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D., & Fauci, A. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.007 · Cited by 174
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Nachbagauer, R., Choi, A., Hirsh, A., Margine, I., Iida, S., Barrera, A., Ferres, M., Albrecht, R. A., García-Sastre, A., Bouvier, N. M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3684 · Cited by 172
Self-citationMargine, I., Palese, P., & Krammer, F. (2013) · Journal of Visualized Experiments · doi:10.3791/51112 · Cited by 169
Self-citationZhu, X., McBride, R., Nycholat, C. M., Yu, W., Paulson, J. C., & Wilson, I. A. (2012) · Journal of Virology · doi:10.1128/jvi.01426-12 · Cited by 167
Wohlbold, T., & Krammer, F. (2014) · Viruses · doi:10.3390/v6062465 · Cited by 166
Self-citationRajendran, M., Nachbagauer, R., Ermler, M. E., Bunduc, P., Amanat, F., Izikson, R., Cox, M. M. J., Palese, P., Eichelberger, M. C., & Krammer, F. (2017) · mBio · doi:10.1128/mbio.02281-16 · Cited by 165
Self-citationInduction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Nachbagauer, R., Wohlbold, T. J., Hirsh, A., Hai, R., Sjursen, H., Palese, P., Cox, R. J., & Krammer, F. (2014) · Journal of Virology · doi:10.1128/jvi.02133-14 · Cited by 164
Self-citationA Beneficiary Role for Neuraminidase in Influenza Virus Penetration through the Respiratory Mucus
Yang, X., Steukers, L., Forier, K., Xiong, R., Braeckmans, K., Reeth, K. V., & Nauwynck, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110026 · Cited by 160
Universal influenza vaccines: Shifting to better vaccines
Scorza, F. B., Tsvetnitsky, V., & Donnelly, J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.085 · Cited by 156
Wan, H., Gao, J., Xu, K., Chen, H., Couzens, L. K., Rivers, K., Easterbrook, J. D., Yang, Y., Zhong, L., Rajabi, M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01203-13 · Cited by 151
Self-citationCarlson, C. M., Turpin, E. A., Moser, L. A., O’Brien, K., Cline, T. D., Jones, J. C., Tumpey, T. M., Katz, J. M., Kelley, L. A., Gauldie, J., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001136 · Cited by 148
Johansson, B. E., Moran, T. M., & Kilbourne, E. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6869 · Cited by 143
Air, G. M., Els, M., Brown, L. E., Laver, W. G., & Webster, R. G. (1985) · Virology · doi:10.1016/0042-6822(85)90157-6 · Cited by 134
Su, B., Wurtzer, S., Rameix‐Welti, M., Dwyer, D. E., van der Werf, S., Naffakh, N., Clavel, F., & Labrosse, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008495 · Cited by 131
Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine
Jegaskanda, S., Reading, P. C., & Kent, S. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400432 · Cited by 130
Wohlbold, T. J., Podolsky, K. A., Chromikova, V., Roubidoux, E. K., Falconieri, V., Meade, P. S., Amanat, F., Tan, J., tenOever, B. R., Tan, G. S., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0011-8 · Cited by 130
Self-citationCate, T. R., Rayford, Y., Niño, D., Winokur, P. L., Brady, R. C., Belshe, R. B., Chen, W. H., Atmar, R. L., & Couch, R. B. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.12.041 · Cited by 128
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
Doyle, T. M., Hashem, A. M., Li, C., Domselaar, G. V., Larocque, L., Wang, J., Smith, D. G. S., Cyr, T. D., Farnsworth, A., He, R., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.018 · Cited by 118
Leon, P. E., He, W., Mullarkey, C. E., Bailey, M. J., Miller, M. S., Krammer, F., Palese, P., & Tan, G. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613225113 · Cited by 118
Self-citationWhy Do Influenza Virus Subtypes Die Out? A Hypothesis
Palese, P., & Wang, T. T. (2011) · mBio · doi:10.1128/mbio.00150-11 · Cited by 115
Wan, H., Yang, H., Shore, D. A., Garten, R. J., Couzens, L. K., Gao, J., Jiang, L., Carney, P. J., Villanueva, J. M., Stevens, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7114 · Cited by 108
Self-citationRockman, S. P., Brown, L. E., Barr, I., Gilbertson, B. P., Lowther, S., Kachurin, A., Kachurina, O., Klippel, J., Bodle, J., Pearse, M. J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02434-12 · Cited by 108
Easterbrook, J. D., Schwartzman, L. M., Gao, J., Kash, J. C., Morens, D. M., Couzens, L. K., Wan, H., Eichelberger, M. C., & Taubenberger, J. K. (2012) · Virology · doi:10.1016/j.virol.2012.06.003 · Cited by 106
Self-citationInfluenza Neuraminidase as a Vaccine Antigen
Eichelberger, M. C., & Wan, H. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_398 · Cited by 100
Self-citationBouvier, N. M., Lowen, A. C., & Palese, P. (2008) · Journal of Virology · doi:10.1128/jvi.01226-08 · Cited by 99
Acid-Induced Membrane Fusion by the Hemagglutinin Protein and Its Role in Influenza Virus Biology
Russell, C. J. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_393 · Cited by 96
Three-dimensional structures of influenza virus neuraminidase-antibody complexes
Colman, P. M., Tulip, W. R., Varghese, J. N., Tulloch, P. A., Baker, A. T., Laver, W. G., Air, G. M., & Webster, R. G. (1989) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1989.0028 · Cited by 85
Wohlbold, T. J., Chromikova, V., Tan, G. S., Meade, P. S., Amanat, F., Comella, P., Hirsh, A., & Krammer, F. (2015) · Journal of Virology · doi:10.1128/jvi.02275-15 · Cited by 78
Self-citationJacobsen, H., Rajendran, M., Choi, A., Sjursen, H., Brokstad, K. A., Cox, R. J., Palese, P., Krammer, F., & Nachbagauer, R. (2017) · mBio · doi:10.1128/mbio.01463-17 · Cited by 73
Self-citationStability of neuraminidase in inactivated influenza vaccines
Sultana, I., Yang, Y., Getie‐Kebtie, M., Couzens, L. K., Markoff, L. J., Alterman, M. A., & Eichelberger, M. C. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.078 · Cited by 66
Self-citationGetie‐Kebtie, M., Sultana, I., Eichelberger, M. C., & Alterman, M. A. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12001 · Cited by 64
Self-citationde Vries, R. D., Nieuwkoop, N. J., Pronk, M., de Bruin, E., Leroux-Roels, G., Huijskens, E. G. W., van Binnendijk, R. S., Krammer, F., Koopmans, M. P. G., & Rimmelzwaan, G. F. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.082 · Cited by 63
Self-citationSchotsaert, M., Ysenbaert, T., Smet, A., Schepens, B., Vanderschaeghe, D., Stegalkina, S. S., Vogel, T. U., Callewaert, N., Fiers, W. C., & Saelens, X. (2016) · Scientific Reports · doi:10.1038/srep24402 · Cited by 63
Venkatramani, L., Bochkareva, E. S., Lee, J. T., Gulati, U., Laver, W. G., Bochkarev, A. V., & Air, G. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.061 · Cited by 60
Cox, F., Kwaks, T., Brandenburg, B., Koldijk, M. H., Klaren, V., Smal, B., Korse, H. J. W. M., Geelen, E., Tettero, L., Zuijdgeest, D., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00399 · Cited by 60
Ben‐Yehuda, A., Joseph, A., Barenholz, Y., Zeira, E., Even‐Chen, S., Louria‐Hayon, I., Babai, I., Zakay‐Rones, Z., Greenbaum, E., Galprin, I., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00251-2 · Cited by 57
Neuraminidase-Mediated, NKp46-Dependent Immune-Evasion Mechanism of Influenza Viruses
Bar‐On, Y., Glasner, A., Meningher, T., Achdout, H., Gur, C., Lankry, D., Vitenshtein, A., Meyers, A. F. A., Mandelboim, M., & Mandelboim, O. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.034 · Cited by 57
Neuraminidase inhibitors: who, when, where?
Nguyen‐Van‐Tam, J. S., Venkatesan, S., Muthuri, S. G., & Myles, P. R. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.020 · Cited by 50
Oh, S., McCaffery, J. M., & Eichelberger, M. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5460-5469.2000 · Cited by 50
Self-citationA Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
Schmidt, P. M., Attwood, R. M., Mohr, P. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016284 · Cited by 49
Doyle, T. M., Li, C., Bucher, D. J., Hashem, A. M., Domselaar, G. V., Wang, J., Farnsworth, A., She, Y., Cyr, T. D., He, R., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.041 · Cited by 48
Biological and Protective Properties of Immune Sera Directed to the Influenza Virus Neuraminidase
Halbherr, S. J., Ludersdorfer, T. H., Ricklin, M. E., Locher, S., Rentsch, M. B., Summerfield, A., & Zimmer, G. (2014) · Journal of Virology · doi:10.1128/jvi.02949-14 · Cited by 47
Hurwitz, J. L., Hackett, C. J., McAndrew, E. C., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1994 · Cited by 46
Mohr, P. G., Deng, Y., & McKimm‐Breschkin, J. L. (2015) · Virology Journal · doi:10.1186/s12985-015-0295-3 · Cited by 46
Smith, G., Sun, X., Bai, Y., Liu, Y. V., Massare, M. J., Pearce, M. B., Belser, J. A., Maines, T. R., Creager, H. M., Glenn, G. M., et al. (2017) · Virology · doi:10.1016/j.virol.2017.06.006 · Cited by 46
Non-neutralizing Antibodies Directed at Conservative Influenza Antigens
Sedova, E. S., Щербинин, Д. Н., Lysenko, A. A., Alekseeva, S. V., Artemova, E. A., & Шмаров, М. М. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-4-22-32 · Cited by 44
Laguio-Vila, M. R., Thompson, M. G., Reynolds, S. B., Spencer, S., Gaglani, M., Naleway, A. L., Ball, S. W., Bozeman, S., Baker, S. F., Martínez‐Sobrido, L., et al. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu115 · Cited by 40
de Vries, R. D., Nieuwkoop, N. J., van der Klis, F. R. M., Koopmans, M. P. G., Krammer, F., & Rimmelzwaan, G. F. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix546 · Cited by 39
Self-citationBabiuk, S., Skowronski, D. M., Serres, G. D., HayGlass, K. T., Brunham, R. C., & Babiuk, L. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10540 · Cited by 39
van der Velden, M. V. W., Fritz, R., Pollabauer, E. M., Portsmouth, D., Howard, M. K., Kreil, T. R., Dvorak, T., Fritsch, S. R. S., Vesikari, T., Díez‐Domingo, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit498 · Cited by 29
Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells
Oh, S., & Eichelberger, M. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7738-7744.2000 · Cited by 28
Self-citationPrevato, M., Ferlenghi, I., Bonci, A., Uematsu, Y., Anselmi, G., Giusti, F., Bertholet, S., Legay, F., Telford, J. L., Settembre, E. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135474 · Cited by 25
Development of recombinant protein-based influenza vaccine
Dalakouras, A., Smith, B. J., Platis, D., Cox, M. M. J., & Labrou, N. E. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.09.067 · Cited by 24
Solano, M. I., Woolfitt, A. R., Williams, T. L., Pierce, C. L., Gubareva, L. V., Mishin, V. P., & Barr, J. R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04902 · Cited by 17
Hackett, C. J., Horowitz, D., Wysocka, M., & Eisenlohr, L. C. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.672-676.1991 · Cited by 14
Cited by
The human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 796
Self-citationFreyn, A. W., Ramos da Silva, J., Rosado, V. C., Bliss, C. M., Pine, M., Mui, B. L., Tam, Y. K., Madden, T. D., de Souza Ferreira, L. C., Weissman, D., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.018 · Cited by 299
Self-citationBroadly protective human antibodies that target the active site of influenza virus neuraminidase
Stadlbauer, D., Zhu, X., McMahon, M., Turner, J. S., Wohlbold, T. J., Schmitz, A. J., Strohmeier, S., Yu, W., Nachbagauer, R., Mudd, P. A., et al. (2019) · Science · doi:10.1126/science.aay0678 · Cited by 260
Self-citationDevelopment of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Chivukula, S., Plitnik, T., Tibbitts, T., Karve, S., Dias, A., Zhang, D., Goldman, R., Gopani, H., Khanmohammed, A., Sarode, A., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00420-6 · Cited by 117
Metadata
- Authors
- Krammer, F., Fouchier, R. A. M., Eichelberger, M. C., Webby, R. J., Shaw-Saliba, K., Wan, H., Wilson, P. C., Compans, R. W., Skountzou, I., & Monto, A. S.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2018-05-02
- Volume
- 9
- Issue
- 2
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2795794761
- Cited by
- 288
- References
- 74
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.